Evaluation of the cost-utility of phosphate binders as a treatment option for hyperphosphatemia in chronic kidney disease patients: a systematic review and meta-analysis of the economic evaluations

BACKGROUND: Uncontrolled hyperphosphatemia in chronic kidney disease (CKD) patients commonly results in vascular calcification leading to increased risk of cardiovascular disease. Phosphate binders (PBs) are used for hyperphosphatemia and can be calcium-based (CBPBs) or non-calcium-based (NCBPBs), t...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaiyakittisopon, Kamolpat, Pattanaprateep, Oraluck, Ruenroengbun, Narisa, Sapankaew, Tunlanut, Ingsathit, Atiporn, Mckay, Gareth J., Attia, John, Thakkinstian, Ammarin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166732/
https://www.ncbi.nlm.nih.gov/pubmed/33677736
http://dx.doi.org/10.1007/s10198-021-01275-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166732/
https://www.ncbi.nlm.nih.gov/pubmed/33677736
http://dx.doi.org/10.1007/s10198-021-01275-3

Ejemplares similares